110 related articles for article (PubMed ID: 33191789)
21. Elevated Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Patients with Mesial Temporal Lobe Epilepsy.
Sun FJ; Wei YJ; Li S; Guo W; Chen X; Liu SY; He JJ; Yin Q; Yang H; Zhang CQ
J Mol Neurosci; 2016 Jun; 59(2):241-50. PubMed ID: 26798047
[TBL] [Abstract][Full Text] [Related]
22. Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
Wang Z; Chen Y; Li X; Xu L; Ma W; Chang L; Ju F
Asian Pac J Cancer Prev; 2012; 13(1):27-31. PubMed ID: 22502683
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Vascular Endothelial Growth Factor Receptor 3 Reduces Migration of Gastric Cancer Cells.
Lim J; Ryu JH; Kim EJ; Ham S; Kang D
Cancer Invest; 2015; 33(8):398-404. PubMed ID: 26115478
[TBL] [Abstract][Full Text] [Related]
25. [Effect of xiaotan sanjie recipe on expressions of VEGF-C and VEGFR-3 in nude mice with transplanted human gastric adenocarcinoma cell MKN-45].
Pang B; Wei PK; Li YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):204-8. PubMed ID: 21425575
[TBL] [Abstract][Full Text] [Related]
26. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
[TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.
Kim JY; Jeon TJ; Bae BN; Kwon JE; Kim HJ; Park K; Shin E
APMIS; 2013 Feb; 121(2):95-104. PubMed ID: 23030255
[TBL] [Abstract][Full Text] [Related]
28. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
29. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
30. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
31. ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells.
Cho HJ; Oh N; Park JH; Kim KS; Kim HK; Lee E; Hwang S; Kim SJ; Park KS
Mol Cancer Res; 2019 Nov; 17(11):2257-2266. PubMed ID: 31511359
[TBL] [Abstract][Full Text] [Related]
32. VEGF-C, VEGFR-3, and COX-2 enhances growth and metastasis of human cervical carcinoma cell lines in vitro.
Shi X; Chen G; Xing H; Weng D; Bai X; Ma D
Oncol Rep; 2007 Jul; 18(1):241-7. PubMed ID: 17549374
[TBL] [Abstract][Full Text] [Related]
33. [Inhibitory effect of nimesulide and oxaliplatin on tumor growth and lymphatic metastasis of transplanted human lung cancer in nude mice].
Lang Z; Chen G; Wang DC
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):739-44. PubMed ID: 23291066
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia.
Shin YJ; Choi JS; Lee JY; Choi JY; Cha JH; Chun MH; Lee MY
Acta Neuropathol; 2008 Nov; 116(5):517-27. PubMed ID: 18704465
[TBL] [Abstract][Full Text] [Related]
35. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer.
Yonemura Y; Fushida S; Bando E; Kinoshita K; Miwa K; Endo Y; Sugiyama K; Partanen T; Yamamoto H; Sasaki T
Eur J Cancer; 2001 May; 37(7):918-23. PubMed ID: 11313181
[TBL] [Abstract][Full Text] [Related]
36. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
37. Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis.
Kinashi H; Ito Y; Sun T; Katsuno T; Takei Y
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142879
[TBL] [Abstract][Full Text] [Related]
38. Fluid shear stress regulates vascular remodeling via VEGFR-3 activation, although independently of its ligand, VEGF-C, in the uterus during pregnancy.
Park YG; Choi J; Jung HK; Song IK; Shin Y; Park SY; Seol JW
Int J Mol Med; 2017 Oct; 40(4):1210-1216. PubMed ID: 28849193
[TBL] [Abstract][Full Text] [Related]
39. [Study on the correlation between the expressions of nm23H1 mRNA, VEGF-C mRNA and lymphatic metastases, survival rate with gastric cancer].
Ding GF; Li JC; Li CS; Xu YF; Sun Y; Chen XR
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Feb; 39(1):46-54. PubMed ID: 16944571
[TBL] [Abstract][Full Text] [Related]
40. Expression Profile of VEGF-C, VEGF-D, and VEGFR-3 in Different Grades of Endometrial Cancer.
Oplawski M; Dziobek K; Zmarzły N; Grabarek B; Halski T; Januszyk P; Kuś-Kierach A; Adwent I; Dąbruś D; Kiełbasiński K; Boroń D
Curr Pharm Biotechnol; 2019; 20(12):1004-1010. PubMed ID: 31333122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
